Case Report: Targeting of individual somatic tumor mutations by multipeptide vaccination tailored for HLA class I and II presentation induces strong CD4 and CD8 T-cell responses in a patient with metastatic castration sensitive prostate cancer

By sjmartinez • November 3, 2023

Zelba H, Rabsteyn A, Bartsch O, Kyzirakos C, Kayser S, Seibold M, Harter J, Latzer P, Hadaschik D, Battke F, Golf A, Rettig MB, Biskup S. Case Report: Targeting of individual somatic tumor mutations by multipeptide vaccination tailored for HLA class I and II presentation induces strong CD4 and CD8 T-cell responses in a patient with metastatic castration sensitive prostate cancer. Front Immunol. 2023 Oct 18;14:1271449. doi: 10.3389/fimmu.2023.1271449. PMID: 37920460; PMCID: PMC10619716.

Tags: APC, Cardiology/Epi, Harbor UCLA, neoantigen, peptide, prostate cancer, Publications, Vaccination

Artificial intelligence in coronary CT angiography: transforming the diagnosis and risk stratification of atherosclerosis

Irannejad K, Mafi M, Krishnan S, Budoff MJ. Artificial intelligence in coronary CT angiography: transforming the diagnosis and risk stratification of atherosclerosis. Int J Cardiovasc[...]

Dietary control of peripheral adipose storage capacity through membrane lipid remodelling

Tol MJ, Shimanaka Y, Bedard AH, Sapia J, Cui L, Colaço-Gaspar M, Hofer P, Ferrari A, Qian K, Kennelly JP, Lee SD, Gao Y, Xiao[...]

Changing Career Focus: Owen Witte Talks with Caius Radu and Johannes Czernin About a Life Dedicated to Science and Discovery

Witte O, Radu C, Czernin J. Changing Career Focus: Owen Witte Talks with Caius Radu and Johannes Czernin About a Life Dedicated to Science and[...]